Floatz logo

CIS-DIAMMINEDICHLOROPLATINUM II

Hemorrhagic Stroke

University Of PerugiaSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Hemorrhagic Stroke cohort.

Asset / SponsorPhaseRating
Lipitor
Duan Chuanzhi
Phase 4BB
Cerebrolysin
Cardinal Stefan Wyszynski University
Phase 4BB
Esmolol
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase 4BB
compound solution of sodium chloride
University Hospital Heidelberg
Phase 2B
Inomax
Cristália Produtos Químicos Farmacêuticos Ltda.
Phase 4B

View all 21 →

Same molecule, other indications

CIS-DIAMMINEDICHLOROPLATINUM II is also rated in:

squamous cell lung carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
primary peritoneal carcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
adenocarcinomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →